News, Commentary & Events: SILJ


10.37up0.27 (2.6733%)

 as of 12:40:15pm ET 11/29/2022
More News:


  • Best & Worst Monthly Performers: October 12 Edition

    ETF Database - 10/12/2022

    Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as potential starting points for those looking to take on either short or long positions. Likewise, traders can also use this list to spot potential trend reversal opportunities that may offer a generous risk/reward. As always, investors of all experience levels are advised to use stop-loss orders and practice disciplined profit-taking techniques. To get access to all ETF Database premium content, sign up for a free 14-day trial to ETF Database Pro.

  • These 10 ETFs Were Last Week's Top Performers: Oct 3, 2022

    ETF Database - 10/03/2022

    These were the best-performing ETFs for the week ending Sept. 30, 2022. NOTE: We’ve excluded funds which use leverage or make inverse bets on their underlying assets. In the past week’s top performers, one theme stood out among the rest: precious metals miners. Gold and silver miner ETFs surged last week, with silver miners seeing particularly strong performance. The ETFMG Prime Junior Silver Miners ETF (SILJ C+) saw the strongest upswing, rising 9.62% on the week, but the Global X Silver Miners ETF (SIL B-) and iShares MSCI Global Silver Miners ETF (SLVP B+) also rose 8.51% and 8.37%, respectively. Gold miners also performed capably, with the VanEck Junior Global Miners ETF (GDXJ B+) rising the most (9.07%). Other top performers included the Sprott Gold Miners ETF (SGDM B-), which increased 8.11%; the US Global GO GOLD and Precious Metal Miners ETF (GOAU ), which rose 8.09%; and the VanEck Gold Miners ETF (GDX B+), which rose 7.49%. Read: Gold’s “Spooky Season” Could Be Ending This October Other top performers included two Simplify ETFs, the Simplify Interest Rate Hedge ETF (PFIX B), which rose 9.02%; and the Simplify Tail Risk Strategy ETF (CYA B), which rose 8.59%. The iShares Neuroscience and Healthcare ETF (IBRN ) saw a 7.95% pop, as well. For more news, information, and analysis, please visit ETF Database.

Technical Events

Technical Analysis

Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. The sale of ETFs is subject to an activity assessment fee (from $0.01 to $0.03 per $1,000 of principal). ETFs are subject to market fluctuation and the risks of their underlying investments. ETFs are subject to management fees and other expenses. Unlike mutual funds, ETF shares are bought and sold at market price, which may be higher or lower than their NAV, and are not individually redeemed from the fund.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF’s prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock Inc., and its affiliates.

Fidelity receives compensation from the funds advisor or its affiliates in connection with a licensing agreement to utilize Fidelity’s active ETF methodology which may create incentives for FBS to encourage the purchase of certain ETFs.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

© 2010 Morningstar, Inc. All rights reserved. The Morningstar information contained herein (1) is proprietary to Morningstar or its affiliates; (2) may not be copied or redistributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.